Clinical Trial Update: Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study update on intravenously administered ALTB-268 in healthy participants, assessing safety, tolerability, PK and PD; Ulcerative Colitis (UC) is liste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ALTB-268

Snippet

Sponsor: AltruBio Inc. | Conditions: Ulcerative Colitis (UC) | Phase 1 | Status: RECRUITING